Parexel Opens D.C.-Area Office

Parexel International has opened a Washington, D.C.-area office, located in Bethesda, MD, as part of an effort to provide clients with improved access to its team of regulatory and product development experts.

“Building upon our existing consulting network in Washington, D.C., Parexel is formalizing its presence in this important government center to better meet client needs,” said Josef H. von Rickenbach, chairman and chief executive officer of Parexel. “With several recent appointments of senior level, Washington, D.C.-based experts who have extensive FDA backgrounds, including Dr. George Mills, formerly a division director at the Agency, we believe Parexel is prepared to meet increasing demand for regulatory expertise from international clients seeking product approval in the U.S.”

“Clients are looking to Parexel Consulting to optimize their product development plans, help them identify the best path to approval, and prepare for and attend milestone meetings with U.S. regulatory authorities. The Washington, D.C.-area office will allow us to promote even more productive interactions between our clients and the FDA, other government agencies, and scientific organizations,” said Kurt Brykman, president of Parexel Consulting and Medical Communications. “Additionally, this location positions us closer to key clients in the Eastern U.S. bio/pharmaceutical corridor, who increasingly need specialized consulting support.”